Log in to save to my catalogue

Evaluation of pneumococcal meningitis clusters in Burkina Faso and implications for potential reacti...

Evaluation of pneumococcal meningitis clusters in Burkina Faso and implications for potential reacti...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7388202

Evaluation of pneumococcal meningitis clusters in Burkina Faso and implications for potential reactive vaccination

About this item

Full title

Evaluation of pneumococcal meningitis clusters in Burkina Faso and implications for potential reactive vaccination

Publisher

Netherlands: Elsevier Ltd

Journal title

Vaccine, 2020-07, Vol.38 (35), p.5726-5733

Language

English

Formats

Publication information

Publisher

Netherlands: Elsevier Ltd

More information

Scope and Contents

Contents

Highlights•From 2011 to 2017, Burkina Faso had 20 pneumococcal meningitis clusters of ≥ 5 cases per district/week. •Clusters had a maximum weekly incidence of 7 cases and a maximum duration of 4 weeks. •Most clusters occurred prior to 13-valent pneumococcal conjugate vaccine introduction. •Clusters were caused by a mixture of serotypes, with seroty...

Alternative Titles

Full title

Evaluation of pneumococcal meningitis clusters in Burkina Faso and implications for potential reactive vaccination

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7388202

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7388202

Other Identifiers

ISSN

0264-410X

E-ISSN

1873-2518

DOI

10.1016/j.vaccine.2020.06.002

How to access this item